论文部分内容阅读
目的:针对子宫肌瘤患者,讨论实施超声引导经皮穿刺微波原位消融治疗的效果,为日后的临床治疗提供参考与指导。方法:将我院收治的子宫肌瘤患者作为研究对象,选择对象的年份在2014年12月-2016年10月,患者总计150例。在分组研究的方法上,通过随机数表法完成,将150例子宫肌瘤患者,随机划分为两组,包括观察组与对照组。针对对照组患者,实施常规开腹治疗;针对观察组患者,实施超声引导经皮穿刺微波原位消融治疗,对比两组患者的临床疗效。结果:经过临床统计,观察组患者显效41例,占比54.7%;有效30例,占比40.0%;无效4例,占比5.3%,治疗总有效率为94.7%。对照组患者显效38例,占比50.7%;有效27例,占比36.0%;无效10例,占比13.3%,治疗总有效率为86.7%,两组患者比较差异有统计学意义,P<0.05,观察组疗效优于对照组。结论:子宫肌瘤患者经过超声引导经皮穿刺微波原位消融治疗后,自身的不良反应较少,多数患者在康复速度上较快,身体上未表现出明显的不适情况。超声引导经皮穿刺微波原位消融的安全性较高,能够结合子宫肌瘤患者的实际表现来完成治疗,可行性较为突出。建议在今后的临床治疗中,将超声引导经皮穿刺微波原位消融治疗推广应用。
OBJECTIVE: To investigate the effect of ultrasound guided percutaneous microwave in situ ablation for patients with uterine fibroids to provide reference and guidance for future clinical treatment. Methods: The patients with myoma of uterus treated in our hospital were selected as the research object. The subjects were selected from December 2014 to October 2016, with a total of 150 patients. In the method of grouping study, completed by random number table, 150 cases of uterine fibroids were randomly divided into two groups, including the observation group and the control group. For the control group of patients, the implementation of routine laparotomy; for the observation group of patients, the implementation of ultrasound-guided percutaneous microwave in situ ablation, compared the clinical efficacy of two groups of patients. Results: After clinical statistics, the observation group of patients markedly effective in 41 cases, accounting for 54.7%; effective in 30 cases, accounting for 40.0%; ineffective in 4 cases, accounting for 5.3%, the total effective rate was 94.7%. The control group of patients markedly effective in 38 cases, accounting for 50.7%; effective in 27 cases, accounting for 36.0%; ineffective in 10 cases, accounting for 13.3%, the total effective rate was 86.7%, the difference between the two groups was statistically significant, P < 0.05, the observation group is better than the control group. CONCLUSION: After uterine fibroids are treated with ultrasound-guided percutaneous microwave ablation, there are few adverse reactions in patients with uterine fibroids. Most patients recover faster and have no obvious physical discomfort. Ultrasound-guided percutaneous microwave in situ ablation of high safety, combined with the actual performance of patients with uterine fibroids to complete the treatment, the feasibility is more prominent. Proposed in the future clinical treatment, the ultrasound guided percutaneous microwave in situ ablation therapy to promote the use of.